These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26233089)

  • 1. Recommendations for the management of symptomatic Clostridium difficile infection (CDI).
    Piekarska A;
    Przegl Epidemiol; 2015; 69(2):289-90, 401-2. PubMed ID: 26233089
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis and management of Clostridium difficile infection.
    Dupont HL
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual case of acute abdomen -? Is it C. difficile infection.
    Limaye CS; Parikh FS; Kamath SA
    J Assoc Physicians India; 2008 Sep; 56():728. PubMed ID: 19086365
    [No Abstract]   [Full Text] [Related]  

  • 4. Clostridium difficile infection.
    Clark T; Wiselka M
    Clin Med (Lond); 2008 Oct; 8(5):544-7. PubMed ID: 18975492
    [No Abstract]   [Full Text] [Related]  

  • 5. Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital.
    Catanzaro M; Cirone J
    Am J Infect Control; 2012 Sep; 40(7):663-6. PubMed ID: 22153847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Clostridium difficile infection.
    Musher DM; Stager C
    Clin Infect Dis; 2012 Jun; 54(11):1675-6. PubMed ID: 22503848
    [No Abstract]   [Full Text] [Related]  

  • 7. Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line.
    Aguado JM; Anttila VJ; Galperine T; Goldenberg SD; Gwynn S; Jenkins D; Norén T; Petrosillo N; Seifert H; Stallmach A; Warren T; Wenisch C;
    J Hosp Infect; 2015 Jun; 90(2):117-25. PubMed ID: 25842241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series.
    Vargo CA; Bauer KA; Mangino JE; Johnston JE; Goff DA
    Pharmacotherapy; 2014 Sep; 34(9):901-9. PubMed ID: 24898525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection, treatment, and prevention of Clostridium difficile infection.
    McCollum DL; Rodriguez JM
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):581-92. PubMed ID: 22433924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on Clostridium difficile infection and its management.
    Smith SM
    Nurs Womens Health; 2010 Oct; 14(5):391-7. PubMed ID: 20955528
    [No Abstract]   [Full Text] [Related]  

  • 14. Environmental interventions to control Clostridium difficile.
    Loo VG
    Infect Dis Clin North Am; 2015 Mar; 29(1):83-91. PubMed ID: 25573675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Re-emergent etiologies: Clostridium difficile].
    Mare A; Man A; Toma F; Szekely E; Lörinczi L
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):181-8. PubMed ID: 19326731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
    Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
    J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does empirical Clostridium difficile infection (CDI) therapy result in false-negative CDI diagnostic test results?
    Sunkesula VC; Kundrapu S; Muganda C; Sethi AK; Donskey CJ
    Clin Infect Dis; 2013 Aug; 57(4):494-500. PubMed ID: 23645849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance assessment of the BD MAX Cdiff assay in comparison to Xpert C. difficile assay in a setting with very low prevalence of toxigenic Clostridium difficile PCR ribotype 027.
    Chiang D; Ng S; La MV; Jureen R; Lin RT; Teo JW
    Anaerobe; 2014 Dec; 30():156-8. PubMed ID: 25305151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could fecal microbiota transplantation cure all Clostridium difficile infections?
    Borody TJ; Peattie D; Kapur A
    Future Microbiol; 2014; 9(1):1-3. PubMed ID: 24328373
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment on: Increasing incidence of community-associated atypical Clostridium difficile disease in children.
    Pant C; Bass PF
    Clin Pediatr (Phila); 2010 Sep; 49(9):907; author reply 908. PubMed ID: 20693524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.